Member of the Board of Directors of PolyPeptide Group
Erik Schropp, Member of the Board of Directors of PolyPeptide Group, is a Dutch citizen born in 1964. Mr. Schropp has served as member of the Board of Directors of PolyPeptide Laboratories Holding B.V. since 2017. Currently, he is CEO of C&P Investors Limited and a director of Draupnir Holding B.V., The Netherlands. Previously, Mr. Schropp held various finance functions in the pharmaceutical industry. Further, Mr. Schropp serves as member of the Board of Directors of various privately held companies engaged in the fields of life sciences, gene therapy and venture capital investment. Mr. Schropp holds a Master’s degree in Economics & Tax from the Erasmus University Rotterdam, The Netherlands.